ABBV: AbbVie Inc. Stock Live Price Graph
About the company
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Virology: MAVYRET offers a treatment option for individuals with chronic HCV genotype 1-6 infection. Gastroenterology and Endocrinology: The company supplies CREON, an enzyme replacement therapy for exocrine pancreatic insufficiency, and Synthroid, used to manage hypothyroidism. Linzess/Constella helps treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation. Women's Health and Urology: Lupron serves as a palliative treatment for conditions like advanced prostate cancer, endometriosis, central precocious puberty, and anemia caused by uterine fibroids. ORILISSA, a nonpeptide small molecule GnRH antagonist, is designed for women experiencing moderate to severe endometriosis pain. Neurology: AbbVie offers Duopa and Duodopa, a levodopa-carbidopa intestinal gel for Parkinson's disease, and Ubrelvy to treat migraines (with or without aura) in adults. The therapeutic formulation of Botox is also part of its offerings. Ophthalmology: Its eye care segment features Lumigan/Ganfort (a bimatoprost ophthalmic solution) and Alphagan/Combigan (an alpha-adrenergic receptor agonist), both aimed at reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Restasis, a calcineurin inhibitor immunosuppressant, is provided to enhance tear production, alongside other specialized eye care products. AbbVie Inc. also engages in research collaborations, including a partnership with Dragonfly Therapeutics, Inc. The company was founded in 2012 and operates from its headquarters in North Chicago, Illinois.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $1.73 | $1.73 | 3.23% | - |
| - | $1.73 | $1.73 | 3.10% | - |
| - | $1.64 | $1.64 | 2.90% | - |
| - | $1.64 | $1.64 | 3.47% | - |
| - | $1.64 | $1.64 | 3.61% | - |
| - | $1.64 | $1.64 | 3.67% | - |
| - | $1.55 | $1.55 | 3.23% | - |
| - | $1.55 | $1.55 | 3.65% | - |
| - | $1.55 | $1.55 | 3.73% | - |
| - | $1.55 | $1.55 | 3.69% | - |
| - | $1.48 | $1.48 | 3.99% | - |
| - | $1.48 | $1.48 | 4.38% | - |
| - | $1.48 | $1.48 | 3.55% | - |
| - | $1.48 | $1.48 | 3.75% | - |
| - | $1.41 | $1.41 | 3.95% | - |
| - | $1.41 | $1.41 | 3.68% | - |
| - | $1.41 | $1.41 | 3.41% | - |
| - | $1.41 | $1.41 | 3.98% | - |
| - | $1.3 | $1.3 | 4.77% | - |
| - | $1.3 | $1.3 | 4.33% | - |
| - | $1.3 | $1.3 | 4.68% | - |
| - | $1.3 | $1.3 | 4.34% | - |
| - | $1.18 | $1.18 | 5.48% | - |
| - | $1.18 | $1.18 | 4.66% | - |
| - | $1.18 | $1.18 | 5.48% | - |
| - | $1.18 | $1.18 | 4.98% | - |
| - | $1.07 | $1.07 | 5.81% | - |
| - | $1.07 | $1.07 | 5.93% | - |
| - | $1.07 | $1.07 | 5.03% | - |
| - | $1.07 | $1.07 | 4.66% | - |
| - | $0.96 | $0.96 | 3.96% | - |
| - | $0.96 | $0.96 | 3.42% | - |
| - | $0.96 | $0.96 | 3.20% | - |
| - | $0.71 | $0.71 | 2.65% | - |
| - | $0.64 | $0.64 | 2.80% | - |
| - | $0.64 | $0.64 | 3.46% | - |
| - | $0.64 | $0.64 | 3.77% | - |
| - | $0.64 | $0.64 | 3.84% | - |
| - | $0.57 | $0.57 | 3.72% | - |
| - | $0.57 | $0.57 | 3.43% | - |
| - | $0.57 | $0.57 | 3.66% | - |
| - | $0.57 | $0.57 | 4.10% | - |
| - | $0.51 | $0.51 | 3.75% | - |
| - | $0.51 | $0.51 | 2.77% | - |
| - | $0.51 | $0.51 | 3.01% | - |
| - | $0.49 | $0.49 | 2.76% | - |
| - | $0.42 | $0.42 | 3.02% | - |
| - | $0.42 | $0.42 | 2.98% | - |
| - | $0.42 | $0.42 | 3.49% | - |
| - | $0.4 | $0.4 | 3.21% | - |
| - | $0.4 | $0.4 | 3.50% | - |
| - | $0.4 | $0.4 | 2.74% | - |
| - | $0.4 | $0.4 | 1.85% | - |
| - | $0.4 | $0.4 | 1.18% | - |
What Is ABBV? Live ABBV Prices and Analysis
AbbVie Inc. (ABBV) is a global biopharmaceutical company that emerged from Abbott Laboratories in 2013. Known for its robust portfolio, AbbVie specializes in the research and development of innovative therapies, particularly in immunology, oncology, and neuroscience. Investors closely monitor ABBV due to its strong market presence, significant research capabilities, and a solid pipeline of products, making it a key player in the healthcare sector.
As a major pharmaceutical entity, AbbVie plays a crucial role in the economy by providing life-saving medications and contributing to employment in the healthcare industry. Its performance is often scrutinized by investors, analysts, and market watchers alike, given the increasing demand for advanced medical solutions.
Market Context
AbbVie operates in a dynamic market environment influenced by various factors, including international trade policies and regulatory changes. The pricing of ABBV shares is primarily denominated in U.S. dollars, which can impact its valuation in global markets. Additionally, the stock can exhibit volatility based on earnings reports, product approvals, and broader market sentiment regarding the pharmaceutical sector.
Why Do ABBV Prices Rise or Fall?
The stock price of AbbVie can fluctuate due to several interrelated factors that investors should consider when evaluating its performance:
- Earnings Reports: Quarterly earnings can significantly influence investor sentiment and stock price.
- Regulatory Approvals: Success or failure in obtaining FDA approval for new drugs can cause price swings.
- Market Competition: The entry of generic competitors or new therapies can impact AbbVie's market share.
- Pipeline Developments: Advancements in clinical trials and new product launches can drive investor confidence.
- Dividends: Changes in dividend policy can attract or deter investors focused on income.
- Macro-Economic Factors: Broader economic conditions, such as interest rates and inflation, can affect stock valuations.
- Investor Sentiment: Overall market sentiment towards the healthcare sector can influence ABBV's stock price.
- Mergers and Acquisitions: Rumors or announcements regarding potential mergers can create volatility.
Understanding these factors can help investors make informed decisions regarding ABBV stock, as they collectively contribute to the company's market performance.
Why Is Live ABBV Price Tracking Important?
Tracking the live price of ABBV is essential for investors for several reasons:
- Real-time Data: Access to live prices allows investors to react promptly to market changes.
- Investment Timing: Monitoring price movements helps in identifying optimal entry and exit points.
- Market Trends: Live tracking can reveal trends that may not be apparent through delayed data.
- Portfolio Management: Investors can manage their holdings more effectively with up-to-date information.
- Strategic Decisions: Real-time data supports better decision-making regarding buying or selling shares.
What Should You Consider When Trading / Investing in ABBV?
Investing in ABBV, like any stock, comes with inherent risks. Investors should consider the following:
- Volatility: ABBV can experience significant price fluctuations, which may not be suitable for all investors.
- Regulatory Risks: The pharmaceutical industry is highly regulated, and changes in laws can impact profitability.
- Market Trends: Broader trends in the healthcare sector can influence ABBV’s stock performance.
- Earnings Volatility: Earnings surprises, both positive and negative, can lead to sharp price movements.
- Research and Development: The success of ongoing clinical trials is critical for future growth.
What Can You Find on the Investvio ABBV Page?
- Live Price: Up-to-date stock price and market capitalization.
- Charts: Interactive charts for technical analysis and historical performance.
- Technical Analysis: Insights into market trends and stock movements.
- News: Latest news articles and updates regarding AbbVie and the pharmaceutical sector.
- Earnings Reports: Access to past and upcoming earnings information.
- Dividend Information: Current dividend yield and payment history.
In conclusion, AbbVie Inc. (ABBV) represents a significant opportunity within the biopharmaceutical sector. Investors can leverage the resources available on Investvio to stay informed and make strategic investment decisions based on comprehensive market analysis and real-time data.